These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15776146)

  • 1. [Incidence and management of infusion reactions to infliximab in 186 italian patients with rheumatoid arthritis: the Padua experience].
    Botsios C; Ostuni P; Todesco S
    Reumatismo; 2005; 57(1):44-51. PubMed ID: 15776146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and management of infusion reactions to infliximab: a large center experience.
    Cheifetz A; Smedley M; Martin S; Reiter M; Leone G; Mayer L; Plevy S
    Am J Gastroenterol; 2003 Jun; 98(6):1315-24. PubMed ID: 12818276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of infliximab treatment in patients with rheumatoid arthritis in a real-world clinical setting: description and evaluation of infusion reactions.
    Kelsall J; Rogers P; Galindo G; De Vera MA
    J Rheumatol; 2012 Aug; 39(8):1539-45. PubMed ID: 22589260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the tolerance of infliximab infusions with or without betamethasone premedication in patients with active rheumatoid arthritis.
    Sany J; Kaiser MJ; Jorgensen C; Trape G
    Ann Rheum Dis; 2005 Nov; 64(11):1647-9. PubMed ID: 16227416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
    Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
    Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of infusion reactions to infliximab in patients with rheumatoid arthritis or spondyloarthritis: experience from an immunotherapy unit of rheumatology.
    Lequerré T; Vittecoq O; Klemmer N; Goëb V; Pouplin S; Menard JF; Daragon A; Mejjad O; Le Loët X
    J Rheumatol; 2006 Jul; 33(7):1307-14. PubMed ID: 16758513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis.
    Okuyama A; Nagasawa H; Suzuki K; Kameda H; Kondo H; Amano K; Takeuchi T
    Ann Rheum Dis; 2011 Feb; 70(2):299-304. PubMed ID: 20980704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model.
    Crandall WV; Mackner LM
    Aliment Pharmacol Ther; 2003 Jan; 17(1):75-84. PubMed ID: 12492735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number.
    Wasserman MJ; Weber DA; Guthrie JA; Bykerk VP; Lee P; Keystone EC
    J Rheumatol; 2004 Oct; 31(10):1912-7. PubMed ID: 15468353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis].
    Wiland P; Głowska A; Chlebicki A; Szechiński J
    Pol Arch Med Wewn; 2002 Nov; 108(5):1055-63. PubMed ID: 12685246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute coronary syndrome after infliximab infusion.
    Abedin M; Scheurich D; Reimold SC; Reimold AM
    Cardiol Rev; 2006; 14(1):50-2. PubMed ID: 16371767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry.
    Choquette D; Faraawi R; Chow A; Rodrigues J; Bensen WJ; Nantel F
    J Rheumatol; 2015 Jul; 42(7):1105-11. PubMed ID: 26077415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
    J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of infusion reactions during infliximab treatment in patients with arthritis.
    Kapetanovic MC; Larsson L; Truedsson L; Sturfelt G; Saxne T; Geborek P
    Arthritis Res Ther; 2006; 8(4):R131. PubMed ID: 16869978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis.
    Augustsson J; Eksborg S; Ernestam S; Gullström E; van Vollenhoven R
    Ann Rheum Dis; 2007 Nov; 66(11):1462-6. PubMed ID: 17502359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful retreatment with infliximab in patients with prior severe infusion reactions.
    Uthman I; Touma Z; El-Sayyad J; Zaitoun F
    Clin Rheumatol; 2006 Jul; 25(4):540-1. PubMed ID: 16211336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of reducing duration of infliximab infusion.
    Fukuyo S; Saito K; Yamaoka K; Sawamukai N; Hirata S; Nawata M; Iwata S; Tanaka Y
    Mod Rheumatol; 2014 Mar; 24(2):275-80. PubMed ID: 24251990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy.
    Kavanaugh A; St Clair EW; McCune WJ; Braakman T; Lipsky P
    J Rheumatol; 2000 Apr; 27(4):841-50. PubMed ID: 10782805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premedication prevents infusion reactions and improves retention rate during infliximab treatment.
    Bartoli F; Bruni C; Cometi L; Blagojevic J; Fiori G; Tofani L; Galluccio F; Furst DE; Matucci Cerinic M
    Clin Rheumatol; 2016 Nov; 35(11):2841-2845. PubMed ID: 27436188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of infliximab infusions in the community setting.
    Ducharme J; Pelletier C; Zacharias R
    Can J Gastroenterol; 2010 May; 24(5):307-11. PubMed ID: 20485705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.